All Product SAVE 10% Use this Code:CP10
All Product SAVE 10% Use this Code:CP10
All Product SAVE 10% Use this Code:CP10
All Product SAVE 10% Use this Code:CP10
All Product SAVE 10% Use this Code : CP10
Afatinib 40 mg
19 people are viewing this product right now
Available Options
| Quantity Value | Price | Quantity | |
|---|---|---|---|
| 28 Tablet/s | $168.00 | ||
| 56 Tablet/s | $330.00 | ||
| 84 Tablet/s | $487.00 |
From: $168.00
Shipping calculated at checkout.
Estimated delivery:5 days
Guarantee Safe and Secure Payment Checkout
Afatinib dimaleate is a medication primarily used in the treatment of metastatic non-small cell lung cancer (NSCLC) that harbors specific genetic mutations known as EGFR (epidermal growth factor receptor) mutations. It belongs to a class of drugs called tyrosine kinase inhibitors, which work by blocking the activity of certain proteins involved in cancer cell growth and spread. Afatinib is specifically indicated for patients with NSCLC whose tumors have EGFR mutations. It is typically taken orally in tablet form.
| Active Ingredient (Generic Name): | Afatinib Dimaleate |
| Manufacturer: | Natco Pharma Ltd. |
| Packaging: | 28 tablets in 1 bottle |
| Strength: | 40 mg |
| Delivery Time: | 6 To 15 days |
| SKU: | Afatinib 40 mg |
Related ProductsRelated ProductsRelated Products
Related Products
Cenforce D For Sale
From: $108.00 This product has multiple variants. The options may be chosen on the product page
Cenforce Fm
From: $104.00 This product has multiple variants. The options may be chosen on the product page
Cenforce Professional
From: $73.00 This product has multiple variants. The options may be chosen on the product page
Cenforce Soft
From: $72.00 This product has multiple variants. The options may be chosen on the product page
Ajanta Ed Trial Pack
From: $150.00 This product has multiple variants. The options may be chosen on the product page
Cenforce 100
From: $55.00 This product has multiple variants. The options may be chosen on the product page
Afatinib 40 mg
From: $168.00
Reviews
There are no reviews yet.